Company or ticker...

Dianthus Therapeutics

Dianthus develops antibody therapies for severe autoimmune diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

DNTH

6.1B

4,574.9

n/a

167.62%

Key Facts

M. Cap

PS

PE

YTD

6.1B

4,574.9

n/a

167.62%

10MA

20MA

50MA

200MA

$DNTH